Encompass Health Corp.

Encompass Health Corp. is the largest owner and operator of inpatient rehabilitation hospitals in the United States. Headquartered in Birmingham, Alabama, the company's mission is to deliver high-quality, integrated inpatient care, aiming to inspire confidence in achieving unparalleled outcomes more quickly and cost-effectively.

The company provides specialized rehabilitative treatment for patients recovering from major injuries or illnesses, including stroke, neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, and complex orthopedic conditions. Services include intensive therapy (three hours a day, five days a week), 24/7 nursing care, and physician oversight, delivered across a national network of 174 inpatient rehabilitation hospitals in 39 states and Puerto Rico. Encompass Health previously operated a home health and hospice business, which was spun off as Enhabit in 2022.

Mark Tarr serves as the President and Chief Executive Officer. Encompass Health recently reported strong first-quarter 2026 results, with net operating revenue increasing 9.0% and Adjusted EBITDA growing 11.2%, leading to an increase in its full-year guidance. The company continues its strategic expansion, opening new hospitals and adding beds to existing facilities. Encompass Health is recognized as America's Most Awarded Leader in Inpatient Rehabilitation by Newsweek and Statista, and is ranked among Fortune's World's Most Admired Companies.

Latest updates

Encompass Health Raises Guidance on Strong Q1, Expansion Accelerates

Event summary

  • Encompass Health reported Q1 2026 revenue of $1.59 billion, a 9.0% increase year-over-year.
  • The company’s Adjusted EBITDA grew 11.2% to $348.8 million.
  • Encompass Health is increasing its full-year 2026 guidance, raising revenue expectations by $15 million and Adjusted EBITDA by $10 million.
  • The company opened a new 49-bed hospital in Irmo, South Carolina, and added 44 beds across existing facilities during the quarter.

The big picture

Encompass Health's strong Q1 performance and raised guidance reflect continued demand for inpatient rehabilitation services, but also highlight the challenges of managing costs and navigating regulatory uncertainty within the healthcare sector. The company's aggressive expansion strategy, while promising, will require careful execution to avoid overextending resources and diluting returns. The $6.4 billion revenue run rate projected for 2026 positions Encompass Health as a dominant player in a fragmented market.

What we're watching

Capacity Utilization
The pace of hospital openings and bed additions will be critical to sustaining revenue growth, especially given the capital expenditure required. Increased competition in the rehabilitation space could impact utilization rates.
Regulatory Risk
Changes in Medicare reimbursement policies, particularly related to the review choice demonstration project, pose a significant risk to Encompass Health's profitability and will require careful navigation.
Labor Costs
The ongoing shortage of healthcare professionals, particularly nurses and therapists, will continue to pressure labor costs and potentially limit Encompass Health's ability to expand services.

Encompass Health CFO to Address BofA Healthcare Conference

Event summary

  • Encompass Health Corp. (EHC) will participate in the BofA Securities 2026 Health Care Conference.
  • The conference will be held May 12-14, 2026, in an unspecified location.
  • Encompass Health CFO Doug Coltharp will deliver a fireside chat on May 12, 2026, from 8:40-9:10 a.m. PT.
  • The presentation will be webcast live and accessible at investor.encompasshealth.com.

The big picture

Encompass Health, as the largest inpatient rehabilitation hospital operator, faces ongoing scrutiny regarding its pricing power and ability to navigate regulatory changes. Participation in this BofA conference signals an effort to engage with investors and proactively manage perceptions of the company's financial health and strategic direction. The conference appearance is a standard practice, but the content of Coltharp’s remarks will be key to understanding the company's current priorities.

What we're watching

Financial Outlook
The CFO's remarks will likely be scrutinized for signals regarding Encompass Health's performance in a potentially challenging reimbursement environment, given ongoing pressures on hospital margins.
Growth Strategy
The conference provides an opportunity to assess whether Encompass Health's expansion strategy, particularly its focus on outpatient services, is gaining traction and contributing to revenue diversification.
Investor Relations
The webcast and fireside chat will reveal the extent to which Encompass Health is proactively addressing investor concerns and managing expectations regarding future growth and profitability.
CID: 3429